Benjamin F. Edwards & Company, Inc. Syros Pharmaceuticals, Inc. Transaction History

Benjamin F. Edwards & Company, Inc.

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2017 Jan 17, 2018	SELL	$8.45 - $17.48 $1,394 - $2,884	-165 Closed	0 $0
Q3 2017 Oct 24, 2017	BUY	$13.52 - $23.75 $2,230 - $3,918	165	165 $2,000

Ticker SYRS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,236,200
Market Cap $43.1M
Description
Syros Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of treatments for cancer and monogenic diseases, and building a pipeline of gene control medicines. The company's lead product candidates are Tamibarotene, a selective retinoic acid receptor alpha agonist, which is in Phase III clinical trial for genomically def...

Get notified when there are updates to the investment portfolio of Benjamin F. Edwards & Company, Inc., based on Form 13F filings with the SEC.

Stay updated on Benjamin F. Edwards & Company, Inc. with notifications on news.